inCerebro Co.
Latest round
- Seed
Last raised
- Oct 2019
Total raised
- Undisclosed
Investors
- 2
About inCerebro Co.
, Ltd. is a research-oriented company for drug development. The company designs new drugs using molecular modeling and AI technology. In 2019, its research institute was established. The next year, 2020, a research collaboration for ICRB-001 with Eulji University and AI platform completion took place. The company uses AI technology to develop anti-cancer medicines namely, ICRB-001, ICRB-002, ICRB-501, and ICRB-502.
Who invested in inCerebro Co.
2 investors across 2 rounds
See all investors in inCerebro Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about inCerebro Co.
Who invested in inCerebro Co.?
inCerebro Co. has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has inCerebro Co. raised?
inCerebro Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did inCerebro Co. last raise money?
inCerebro Co.'s most recent round on record is a Seed, in Oct 2019.
What does inCerebro Co. do?
inCerebro Co. is a pharmaceuticals company.
Where is inCerebro Co. headquartered?
inCerebro Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like inCerebro Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at inCerebro Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like inCerebro Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.